Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples